Medroxyprogesterone acetate inhibits the proliferation of estrogen- and progesterone-receptor negative MFM-223 human mammary cancer cells via the androgen receptor. - Hackenberg,R.; Hawighorst,T.; Filmer,A.; Nia,AH.; Schulz,KD. (Breast Cancer Res Treat, 1993)